INCYTE CORPORATION License and Services Revenue (Deprecated 2018-01-31)
INCYTE CORPORATION (INCY) reported License and Services Revenue (Deprecated 2018-01-31) of $78.00 thousand for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2012-08-03
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $78.00K, a 5.41% increase year-over-year.
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $163.00K, a 30.64% decline year-over-year.
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $141.00K, a 5.22% increase year-over-year.
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $45.00K, a 66.67% decline year-over-year.
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for fiscal 2011 was $495.00K, a 46.77% decline from fiscal 2010.
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for fiscal 2010 was $930.00K, a 73.50% decline from fiscal 2009.
- INCYTE CORPORATION license and services revenue (deprecated 2018-01-31) for fiscal 2009 was $3.51M.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-06-30 | $78.00K 10-Q · filed 2012-08-03 | $242.00K 10-Q · filed 2012-08-03 | $382.00K derived: sum of 3 quarters · filed 2012-08-03 | $427.00K derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $163.00K 10-Q · filed 2012-04-26 | $304.00K derived: sum of 2 quarters · filed 2012-04-26 | $349.00K derived: sum of 3 quarters · filed 2012-04-26 | $423.00K derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $186.00K derived: sum of 2 quarters · filed 2012-02-22 | $260.00K derived: sum of 3 quarters · filed 2012-08-03 | $495.00K 10-K · filed 2012-02-22 |
| 2011-09-30 | $45.00K 10-Q · filed 2011-10-27 | $119.00K derived: sum of 2 quarters · filed 2012-08-03 | $354.00K 10-Q · filed 2011-10-27 | $488.00K derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $74.00K 10-Q · filed 2012-08-03 | $309.00K 10-Q · filed 2012-08-03 | $443.00K derived: sum of 3 quarters · filed 2012-08-03 | $578.00K derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $235.00K 10-Q · filed 2012-04-26 | $369.00K derived: sum of 2 quarters · filed 2012-04-26 | $504.00K derived: sum of 3 quarters · filed 2012-04-26 | $614.00K derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $269.00K derived: sum of 2 quarters · filed 2012-02-22 | $379.00K derived: sum of 3 quarters · filed 2012-02-22 | $930.00K 10-K · filed 2012-02-22 |
| 2010-09-30 | $135.00K 10-Q · filed 2011-10-27 | $245.00K derived: sum of 2 quarters · filed 2011-10-27 | $796.00K 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $110.00K 10-Q · filed 2011-07-28 | $661.00K 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $551.00K 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $3.51M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |